Human growth hormone, genetically engineered

Human growth hormone (hGH) or somatotropin has returned to the limehght recently when genetically engineered material became more readily available and more applications for the drug opened up. 

Problems have resulted from the availability of hormones and other products of genetic engineering. For example, should parents be allowed to request human growth hormone for short children who do not have a pituitary deficiency Should it be available to athletes and to aging people Use of stem cells in genetic therapy raises another set of questions. 

The human growth hormone (HGH), which can only be extracted in minute quantities from the pituitary glands, can now be isolated in larger quantities through genetic engineering. 

With the introduction of genetic engineering in the 1970s it became possible to produce pharmaceutical proteins like human insulin and human growth hormone (hGH) by microbial fermentations, leading to the development of what is often referred to as the biotech industry. 

Producing and testing N/A genetically engineered interferon monoclonal antibodies production and testing of hormonal proteins, including human growth hormone. 

Common molecular principles underscore the diversity of life, which enable us to produce essential substances, such as insulin for diabetics, using bacteria as the manufacturing machine. Other substances, such as the human growth hormone, are being genetically engineered as well. 

One of the first applications of genetic engineering was the synthesis of human insulin. Previously, diabetics usually had to use either pig or cow insulin, which is not exactly the same as human insulin. Today, most insulin used is produced using Exoli. Human growth hormone is also commercially produced by using recombinant DNA technology. 

---